Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00343_DB06335_nanopub.RAi0SGwnEKk0WmGB6hKxifRkks2V3_OY59XvtpGYHEIbI#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00343_DB06335 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00343_DB06335 label "DDI between Diltiazem and Saxagliptin - Diltiazem is a moderate inhibitor of CYP3A4 and increases AUC of saxagliptin by 109%. Exposure of the active metabolite decreased by 34%. However, these changes in pharmacokinetics are not clinical significant. [drugbank_resource:DB00343_DB06335]" assertion.
- drugbank_resource:DB00343_DB06335 identifier "drugbank_resource:DB00343_DB06335" assertion.
- drugbank_resource:DB00343_DB06335 title "DDI between Diltiazem and Saxagliptin - Diltiazem is a moderate inhibitor of CYP3A4 and increases AUC of saxagliptin by 109%. Exposure of the active metabolite decreased by 34%. However, these changes in pharmacokinetics are not clinical significant." assertion.
- drugbank:DB00343 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00343_DB06335 assertion.
- drugbank:DB06335 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00343_DB06335 assertion.